These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8447376)

  • 1. Inhibition of renal ornithine decarboxylase activity prevents kidney hypertrophy in experimental diabetes.
    Pedersen SB; Flyvbjerg A; Richelsen B
    Am J Physiol; 1993 Feb; 264(2 Pt 1):C453-6. PubMed ID: 8447376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of renal ornithine decarboxylase activity fails to reduce kidney size and urinary albumin excretion in diabetic rats with manifest kidney hypertrophy.
    Pedersen SB; Bjørn SF; Richelsen B; Flyvbjerg A
    Mol Cell Endocrinol; 1995 Jan; 107(1):123-8. PubMed ID: 7796931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes.
    Thomson SC; Deng A; Bao D; Satriano J; Blantz RC; Vallon V
    J Clin Invest; 2001 Jan; 107(2):217-24. PubMed ID: 11160138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal ornithine decarboxylase activity, polyamines, and compensatory renal hypertrophy in the rat.
    Humphreys MH; Etheredge SB; Lin SY; Ribstein J; Marton LJ
    Am J Physiol; 1988 Aug; 255(2 Pt 2):F270-7. PubMed ID: 3136663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased ornithine decarboxylase activity in kidneys undergoing hypertrophy in experimental diabetes.
    Pedersen SB; Flyvbjerg A; Grønbaek H; Richelsen B
    Mol Cell Endocrinol; 1992 Jul; 86(1-2):67-72. PubMed ID: 1511780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyamines and intestinal epithelial hyperplasia in streptozotocin-diabetic rats.
    Younoszai MK; Parekh VV; Hoffman JL
    Proc Soc Exp Biol Med; 1993 Feb; 202(2):206-11. PubMed ID: 8424111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the role of polyamines in different models of kidney hypertrophy in mice.
    Tovar A; Sánchez-Capelo A; Cremades A; Peñafiel R
    Kidney Int; 1995 Sep; 48(3):731-7. PubMed ID: 7474658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of ornithine decarboxylase in distal tubules of early diabetic rat kidneys: are polyamines paracrine hypertrophic factors?
    Deng A; Munger KA; Valdivielso JM; Satriano J; Lortie M; Blantz RC; Thomson SC
    Diabetes; 2003 May; 52(5):1235-9. PubMed ID: 12716758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tyrosine kinase, ODC, and p34cdc2 kinase and cyclin B-associated cdc2 in jejunal enterocyte proliferation, maturation, and exfoliation in diabetic and DFMO-treated rats.
    Parekh VV; Hoffman JL; Younoszai MK
    J Investig Med; 1999 Sep; 47(8):397-404. PubMed ID: 10510592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effects of an ornithine decarboxylase inhibitor on lupus nephritis reveal a post-transcriptional modification of the enzyme.
    Hsu HC; Thomas T; Seibold JR; Thomas TJ
    Agents Actions; 1993; 39 Spec No():C204-6. PubMed ID: 8273569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine and ornithine metabolizing enzymes in testosterone-induced hypertrophic mouse kidney.
    Manteuffel-Cymborowska M; Chmurzyńska W; Peska M; Grzelakowska-Sztabert B
    Int J Biochem Cell Biol; 1995 Mar; 27(3):287-95. PubMed ID: 7780833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornithine decarboxylase along the mouse and rat nephron.
    Levillain O; Hus-Citharel A
    Am J Physiol; 1998 Jun; 274(6):F1020-8. PubMed ID: 9841492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal development of ornithine decarboxylase and polyamines in the mouse kidney: influence of testosterone.
    Sánchez-Capelo A; Peñafiel R; Tovar A; Galindo JD; Cremades A
    Biol Neonate; 1994; 66(2-3):119-27. PubMed ID: 7993945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of streptozotocin-induced diabetes on renal ornithine decarboxylase activity.
    Levine JH; Buse MG; Leaming AB; Raskin P
    Diabetes; 1980 Jul; 29(7):532-5. PubMed ID: 6445842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased ornithine decarboxylase activity in the kidneys of Dahl salt-sensitive rats.
    Hayashi T; Tsujino T; Iwata S; Nonaka H; Emoto N; Yano Y; Otani S; Hayashi Y; Itoh H; Yokoyama M
    Hypertens Res; 2002 Sep; 25(5):787-95. PubMed ID: 12452334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of tumor burden on ornithine decarboxylase activity in mice.
    Saydjari R; Alexander RW; Upp JR; Poston GJ; Barranco SC; Townsend CM; Thompson JC
    Cancer Invest; 1991; 9(4):415-9. PubMed ID: 1884248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of ornithine decarboxylase and polyamines in pancreatic growth of neonatal rats.
    Morisset J; Grondin G
    Pancreas; 1987; 2(3):303-11. PubMed ID: 3114741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of rat brain ornithine decarboxylase by GTP.
    Kilpeläinen PT; Hietala OA
    Biochem J; 1994 Jun; 300 ( Pt 2)(Pt 2):577-82. PubMed ID: 8002964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of proximal small intestinal mucosal growth by luminal polyamines.
    Wang JY; McCormack SA; Viar MJ; Johnson LR
    Am J Physiol; 1991 Sep; 261(3 Pt 1):G504-11. PubMed ID: 1716059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
    Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
    Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.